Ye Feng Selected Research

site 1 membrane-bound transcription factor peptidase

1/2021

Site-1 Protease-Derived Soluble (Pro)Renin Receptor Contributes to Angiotensin II-Induced Hypertension in Mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ye Feng Research Topics

Disease

29	Neoplasms (Cancer) 09/2022 - 10/2012
10	Fibrosis (Cirrhosis) 11/2019 - 04/2016
9	Inflammation (Inflammations) 09/2022 - 01/2018
8	Stomach Neoplasms (Stomach Cancer) 01/2021 - 03/2015
7	Breast Neoplasms (Breast Cancer) 06/2018 - 10/2014
6	Kidney Diseases (Kidney Disease) 01/2020 - 09/2017
5	Insulin Resistance 01/2022 - 02/2015
5	Acute Kidney Injury (Acute Renal Failure) 01/2021 - 04/2016
5	Colorectal Neoplasms (Colorectal Cancer) 01/2021 - 01/2016
5	Neoplasm Metastasis (Metastasis) 07/2020 - 10/2012
5	Infections 04/2020 - 01/2008
4	Type 2 Diabetes Mellitus (MODY) 01/2022 - 02/2015
4	Sepsis (Septicemia) 08/2021 - 04/2017
4	Alzheimer Disease (Alzheimer's Disease) 02/2021 - 01/2012
4	Colonic Neoplasms (Colon Cancer) 07/2019 - 07/2013
3	Hyperglycemia 01/2022 - 01/2019
3	Body Weight (Weight, Body) 01/2022 - 03/2015
3	Proteinuria 01/2021 - 01/2018
3	Chronic Renal Insufficiency 01/2020 - 04/2016
2	Obesity 01/2022 - 02/2021
2	Metabolic Diseases (Metabolic Disease) 02/2021 - 04/2019
2	Mitochondrial Diseases (Mitochondrial Disease) 02/2021 - 01/2020
2	Diabetic Nephropathies (Diabetic Nephropathy) 01/2021 - 01/2019
2	Hypertension (High Blood Pressure) 01/2021 - 04/2017
2	Necrosis 01/2021 - 01/2017
2	Rabies (Hydrophobia) 01/2020 - 01/2018
2	Albuminuria 01/2019 - 01/2018
2	IGA Glomerulonephritis (IGA Nephropathy) 11/2018 - 01/2018
2	Ascites 01/2018 - 10/2015
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 04/2015 - 04/2015
2	Adenocarcinoma 01/2014 - 01/2013
2	Neurodegenerative Diseases (Neurodegenerative Disease) 07/2013 - 01/2012
1	Parkinson Disease (Parkinson's Disease) 09/2022
1	Malaria 02/2022
1	Hypertrophy 01/2022
1	Diarrhea 01/2022
1	Thrombosis (Thrombus) 01/2022
1	Cholangiocarcinoma 01/2022
1	Whooping Cough (Pertussis) 03/2021
1	Hepatocellular Carcinoma (Hepatoma) 01/2021
1	Sclerosis 01/2021

Drug/Important Bio-Agent (IBA)

12	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2013
10	Proteins (Proteins, Gene)FDA Link 01/2021 - 01/2013
6	Pharmaceutical PreparationsIBA 01/2022 - 01/2015
6	MicroRNAs (MicroRNA)IBA 01/2021 - 10/2016
4	AlbuminsIBA 01/2022 - 03/2015
4	Messenger RNA (mRNA)IBA 01/2021 - 01/2018
4	Monoclonal AntibodiesIBA 01/2018 - 01/2014
3	XenobioticsIBA 01/2022 - 04/2019
3	Anti-Bacterial Agents (Antibiotics)IBA 01/2021 - 06/2012
3	Long Noncoding RNAIBA 01/2021 - 01/2018
3	RNA (Ribonucleic Acid)IBA 01/2021 - 10/2016
3	Cisplatin (Platino)FDA LinkGeneric 01/2021 - 04/2016
3	Docetaxel (Taxotere)FDA Link 07/2020 - 01/2016
3	Fluorouracil (Carac)FDA LinkGeneric 07/2020 - 12/2016
3	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2020 - 01/2019
3	Interleukin-6 (Interleukin 6)IBA 01/2019 - 03/2015
3	Mechanistic Target of Rapamycin Complex 2IBA 10/2018 - 01/2017
3	CateninsIBA 06/2018 - 04/2016
3	ErbB Receptors (EGF Receptor)IBA 06/2018 - 01/2013
3	Estrogen ReceptorsIBA 10/2016 - 04/2013
2	Constitutive Androstane ReceptorIBA 01/2022 - 02/2021
2	Benzene (Benzole)IBA 01/2022 - 02/2021
2	Peptides (Polypeptides)IBA 01/2021 - 01/2019
2	C-Reactive ProteinIBA 01/2021 - 03/2015
2	Therapeutic UsesIBA 05/2020 - 07/2013
2	Interleukin-10 (Interleukin 10)IBA 01/2020 - 01/2020
2	ORALIT (ORS)IBA 07/2018 - 01/2017
2	Biological ProductsIBA 02/2018 - 01/2008
2	QuercetinIBA 01/2018 - 04/2016
2	Metformin (Glucophage)FDA LinkGeneric 08/2017 - 04/2016
2	Celecoxib (Celebrex)FDA Link 08/2017 - 10/2016
2	AmberIBA 01/2017 - 01/2017
2	TOR Serine-Threonine KinasesIBA 01/2017 - 04/2016
2	Antineoplastic Agents (Antineoplastics)IBA 11/2013 - 10/2012
2	Virulence Factors (Pathogenicity Factors)IBA 12/2010 - 01/2008
1	Adenosine Triphosphate (ATP)IBA 09/2022
1	Culture MediaIBA 09/2022
1	hemozoinIBA 02/2022
1	SeleniumIBA 02/2022
1	Fibrinogen (Factor I)FDA Link 01/2022
1	SolutionsIBA 01/2022
1	shenling baizhu sanIBA 01/2022
1	Glucose (Dextrose)FDA LinkGeneric 08/2021
1	MacrolidesIBA 03/2021
1	23S Ribosomal RNAIBA 03/2021
1	1,4- bis(2- (3,5- dichloropyridyloxy))benzeneIBA 02/2021
1	Reactive Oxygen Species (Oxygen Radicals)IBA 02/2021
1	Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA 02/2021
1	Azithromycin (Zithromax)FDA LinkGeneric 01/2021
1	Angiotensin IIIBA 01/2021

Therapy/Procedure

16	Therapeutics 08/2021 - 01/2012
6	Drug Therapy (Chemotherapy) 07/2020 - 07/2013
2	Gastrectomy 07/2020 - 10/2016
2	Colectomy 07/2020 - 01/2008
2	Chemoradiotherapy 07/2020 - 04/2015
2	Aftercare (After-Treatment) 04/2015 - 04/2015
1	Ligation 09/2022
1	Cell Transplantation 01/2022
1	Catheters 08/2021